This site is intended for healthcare professionals
Bladder cancer cells on a pink background

Bridging educational gaps across the PTLD pathway

​​Supported by Pierre Fabre​
Last updated: 4th Sep 2026
Published: 4th Sep 2026

Thank you for watching the videos. Please answer these final questions to earn your CME credit.

1. In a patient with unexplained left ventricular hypertrophy, which combination of findings would most strongly support a diagnosis of Fabry disease?

2. Which patient presentation should most strongly prompt evaluation for Fabry disease?

3. Which statement regarding Fabry disease management during pregnancy is most consistent with current evidence?

4. Question 4

5. The activity has been scientifically rigorous and evidence-based
6. I have identified bias
C. If yes, it has been

7. Please rate your level of agreement with the following statements (5 = Strongly agree; 1 = Strongly disagree):

Please complete the fields below to claim your CME credit.

Optional: I confirm that I am happy to receive further information about this video series and relevant Medthority updates by email.

Developed by EPG Health for Medthority. This content has been developed independently of the sponsor, Pierre Fabre, which has had no editorial input into the content. EPG Health received unrestricted educational funding from the sponsor in order to help provide its healthcare professional members with access to the highest quality medical and scientific information, education and associated relevant content. This content is intended for healthcare professionals only.